This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas—d.f., The University of Chicago, University of Pittsburgh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: The Innovative Contributions of Bernadette R. Gochuico
Introduction
Bernadette R. Gochuico is a notable inventor based in Potomac, MD (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of pulmonary diseases. Her work has the potential to improve the diagnosis and evaluation of idiopathic pulmonary fibrosis (IPF), a serious lung condition.
Latest Patents
Gochuico holds a patent for "Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation." This invention relates to the discovery that a panel of serum or plasma markers can be utilized to diagnose IPF and differentiate it from other lung ailments. Additionally, her research identifies markers associated with the progression of IPF, which could lead to better patient management and treatment options. She has 1 patent to her name.
Career Highlights
Throughout her career, Gochuico has worked with prestigious institutions, including the University of Chicago and the Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas. Her experience in these organizations has allowed her to collaborate with leading experts in the field of pulmonary medicine.
Collaborations
Some of her notable coworkers include Naftali Kaminski and Thomas J. Richards. Their collaborative efforts have contributed to advancements in understanding and diagnosing pulmonary diseases.
Conclusion
Bernadette R. Gochuico's innovative work in the field of medical diagnostics highlights her commitment to improving healthcare outcomes for patients with idiopathic pulmonary fibrosis. Her contributions are paving the way for future advancements in the diagnosis and treatment of this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile